<h1>Regulatory empowerment: Shanghai advances full chain biopharmaceutical innovation through clusters, a TBT research base and funding partnerships.</h1> Shanghai advanced full-chain biopharmaceutical innovation by combining regulatory empowerment, industrial cluster launches, and financing mechanisms: policy briefings and regulatory participation accompanied the unveiling of a Trade Research and Evaluation Base (TBT Base), the formal launch of three high-end medical device clusters, and the announcement of a state-owned capital investment cooperation fund to support the biopharmaceutical ecosystem and foster international collaboration.